BUSINESS● LOWSep 19 · Sep 19, 2026, 4:23 PM
Study attempts to find out how India made expensive diabetes medicines affordable
The Hindu · south asia
India’s low medication prices are tied to its role as a major pharmaceutical exporter, supported by legislation that prevents ‘patent evergreening’ and enables generic drug manufacturing, says a study by diabetologists
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowIn Ivory Coast, how Lionel Soulard became the essential face of Cargill in cocoaJeune AfriqueBUSINESS32m agoBank of America in charts: Consumer banking revenue +4% Y/Y, global wealth and investment management +13%Seeking Alpha Tech